New Triple-Drug cocktail aims to shrink Hard-to-Treat kidney tumors
Disease control
Recruiting now
This study is testing whether a combination of three drugs—sasanlimab, palbociclib, and axitinib—can shrink or control advanced kidney cancer that has spread. About 25 adults with clear cell or translocation renal cell carcinoma will receive the drugs and be monitored for tumor r…
Phase: PHASE2 • Sponsor: Stephanie Berg • Aim: Disease control
Last updated May 11, 2026 20:39 UTC